Identifying early cardiovascular disease to target candidates for treatment

Area of Science:

• Cardiology
• Vascular Medicine
• Biomarkers

Background:

• Traditional cardiovascular risk factors fail to identify underlying atherosclerotic disease or its severity.
• There is a need for precise markers to detect early cardiovascular disease and predict future events.

Purpose of the Study:

• To develop and evaluate a novel composite disease score for early cardiovascular disease detection.
• To assess the utility of combining vascular and cardiac tests for improved risk stratification.

Main Methods:

• Utilized 7 vascular tests: artery elasticity, blood pressure response, fundus photography, carotid intima-media thickness, and microalbuminuria.
• Incorporated 3 cardiac tests: electrocardiography, [N-terminal pro-] B-type natriuretic peptide, and left ventricular ultrasonography.
• Developed a scoring system where each test is scored individually, and a total disease score is calculated.

Main Results:

• A comprehensive disease score was developed by integrating multiple vascular and cardiac parameters.
• Individual test scores are summed to create a total disease score, reflecting overall cardiovascular disease burden.
• An ongoing study is comparing this new score against the Framingham risk estimate for predicting cardiovascular events.

Conclusions:

• The novel disease score offers a more precise method for early cardiovascular disease detection than traditional risk factors.
• This integrated approach has the potential to enhance the precision of early detection and treatment strategies.
• Further research is underway to validate its predictive power for cardiovascular events.